AstraZeneca launches US$1.5bil annual savings plan to fund drug pipeline

AstraZeneca has launched a US$1.5 billion annual savings plan aimed at investing in its drug pipeline, according to Free Malaysia Today. The report notes drugmakers face growing scrutiny over late-stage trial success.

Timeline

1. 30 Oct, 08:13 UTCFree Malaysia Today reports savings plan launch

Top sources

• AstraZeneca launches US$1.5bil annual savings plan to invest in drug pipelineFree Malaysia Today